Global E-Health Forum to Present Strategies, Solutions and Services

25 - 26 October 2010, Hamburg, Germany.
Healthcare systems all over the world are facing very similar challenges: demographic shifts, the impact of globalization and an increased burden of chronic diseases and expensive treatments, to mention some of the most important ones. The Global E-Health Forum will addresses these challenges. The first conference day at the Hamburg Chamber of Commerce will feature strategy and best practice presentation, workshops, discussion forums and an accompanying exhibition. The second day will be hosted by Asklepios Clinics. There, conference attendees may expect show cases, hands-on presentations and guided tours as well as a panel discussion titled "Connecting Competence for E-Health Services - What Customers Expect, What Healthcare Has to Deliver". The official reception for the international audience will take place at the U.S. Consulate General.

"Countries all over the world are facing manifold challenges regarding their healthcare delivery. Due to limited budgets and increasing demand for high-quality healthcare services, new cost-efficient, reliable and interconnected systems need to be developed", explains Ljubisav Matejevic, founder and director of the Global E-Health Forum. "This is the reason why after three Baltic Conferences on E-Health (2007-2009), we have decided to found the Global E-Health Forum," continues Ljubisav Matejevic. "E-health, meaning the application of information and communication technologies across the whole range of functions that affect the health sector, can make an important contribution to ensure a high-quality healthcare service for all citizens now and in the future.”

In keynote presentations, speakers from the U.S., Europe and New Zealand will explain their e-health strategies. Harry Reynolds, chairman of the National Committee on Vital and Health Statistics (NCVHS) and chairman of the Council for Affordable Quality Healthcare (CAQH) CORE Initiative will start this program session with his presentation titled "U.S. Health Reform: Significant Change, Varied Reaction, Opportunities Abound, and Outcome Uncertain".

The second program session will deal with best practices, for example presenting the hospital information system of Severance Cardiovascular Hospital in Seoul, South Korea. Other best practices featured will be a medical decision support system for general practitioners and interesting solutions regarding questions of quality management and process optimization.

The program will also include various breakout sessions with workshops and discussion forums where e.g. sustainable telemedicine services will be presented.

The organizers of the Global E-Health Forum - European Health Telematics Association (EHTEL), Hamburg Chamber of Commerce and IBM - have identified in Asklepios an excellent cooperation partner. Recognized as one of the most innovative leading hospital chains (the group oversees over 100 institutions, almost 40 day clinics, around 22,000 beds and 36,000 staff in Germany, Europe and the USA), Asklepios takes care of over one million patients every year. At Asklepios Clinics in Hamburg, attendees may expect more best practice solutions and hands-on experience. However, another important part will be the "services session" meaning the patients' and consumers' perspective / patient-centric e-health services. Uwe Poettgen, CIO of the Asklepios Group, will introduce this topic with a presentation entitled "Connecting Competence for E-Health Services - What Customers Expect, What Healthcare Has to Deliver".

The primary aim of the English-language conference is to provide a cross-sector forum for approximately 200 representatives from hospitals and clinics, governments, health insurance organizations, service providers and the media. Policymakers, users, suppliers and implementation managers will have the opportunity to exchange views and experiences among all those involved in health management. The impact of globalization on healthcare systems and services will be discussed as well as the resulting requirements regarding interconnectivity, interoperability and standardization as well as the need for cross border co-operation.

Among the supporters of this year's conference are the European Association of Healthcare IT Managers, Koch-Mechnikov-Forum, German Hospital Society, U.S. Commercial Service, Finpro, Business Institute (Croatia), and FOM University of Applied Sciences.

For further information and registration, please visit:
http://www.global-ehealth-forum.com

Most Popular Now

Xenpozyme™ (olipudase alfa-rpcp) approved by FDA a…

The U.S. Food and Drug Administration (FDA) has approved Xenpozyme™ (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid...

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Research reveals widespread use of ineffective COV…

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

Efficacy, cash and more will increase booster shot…

The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 vaccine (COMIRNATY® Original/Om...